Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients ; volume:32 ; number:5 ; day:30 ; month:1 ; year:2018 ; pages:1254-1258 ; date:5.2018
Leukemia ; 32, Heft 5 (30.1.2018), 1254-1258, 5.2018
- Creator
-
Nicolosi, Maura
- Contributor
-
Mudireddy, Mythri
Lasho, Terra L.
Hanson, Curtis A.
Ketterling, Rhett P.
Gangat, Naseema
Pardanani, Animesh
Tefferi, Ayalew
SpringerLink (Online service)
- DOI
-
10.1038/s41375-018-0028-x
- URN
-
urn:nbn:de:101:1-2018071323113773453784
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nicolosi, Maura
- Mudireddy, Mythri
- Lasho, Terra L.
- Hanson, Curtis A.
- Ketterling, Rhett P.
- Gangat, Naseema
- Pardanani, Animesh
- Tefferi, Ayalew
- SpringerLink (Online service)
Other Objects (12)
Momelotinib: an emerging treatment for myelofibrosis patients with anemia
How I manage anemia related to myelofibrosis and its treatment regimens
Myelofibrosis
Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients
Myelofibrosis Treatment Algorithm 2018
Novel approaches in myelofibrosis
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
Prefibrotic myelofibrosis: treatment algorithm 2018
Concerns regarding myelofibrosis-type megakaryocyte dysplasia
Management of myelofibrosis after ruxolitinib failure
Myelofibrosis treatment history and future prospects
Prognostic and Predictive Models in Myelofibrosis
Momelotinib: an emerging treatment for myelofibrosis patients with anemia
How I manage anemia related to myelofibrosis and its treatment regimens
Myelofibrosis
Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients
Myelofibrosis Treatment Algorithm 2018
Novel approaches in myelofibrosis
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
Prefibrotic myelofibrosis: treatment algorithm 2018
Concerns regarding myelofibrosis-type megakaryocyte dysplasia
Management of myelofibrosis after ruxolitinib failure
Myelofibrosis treatment history and future prospects
Prognostic and Predictive Models in Myelofibrosis
Momelotinib: an emerging treatment for myelofibrosis patients with anemia
How I manage anemia related to myelofibrosis and its treatment regimens
Myelofibrosis
Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients
Myelofibrosis Treatment Algorithm 2018
Novel approaches in myelofibrosis
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
Prefibrotic myelofibrosis: treatment algorithm 2018
Concerns regarding myelofibrosis-type megakaryocyte dysplasia
Management of myelofibrosis after ruxolitinib failure
Myelofibrosis treatment history and future prospects